Arrowhead Pharma
(ARWR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
| 12-2010 | 09-2010 | 06-2010 | 03-2010 | 12-2009 | |
| Sales | 296 | 0 | 0 | 0 | 148 |
| Gross Profit | 296 | N/A | N/A | N/A | 148 |
| Operating Expenses | 3,632 | 736 | 1,392 | 1,397 | 2,308 |
| Operating Income | -3,336 | -884 | -1,392 | -1,397 | -2,160 |
| Other Income | 529 | 173 | 1,476 | -58 | -71 |
| Pre-tax Income | -2,806 | -711 | 84 | -1,455 | -2,231 |
| Net Income Continuous | -2,806 | -711 | 84 | -1,455 | -2,231 |
| Net Income Discontinuous | 1,575 | -1,603 | -768 | -688 | 414 |
| Minority Interests | 206 | -310 | -313 | -289 | -272 |
| Net Income | $-1,438 | $-2,004 | $-371 | $-1,854 | $-1,545 |
| EPS Basic Total Ops | -0.20 | -0.20 | -0.10 | -0.30 | -0.30 |
| EPS Basic Continuous Ops | -0.42 | 0.10 | 0.01 | -0.20 | -0.40 |
| EPS Basic Discontinuous Ops | 0.22 | -0.31 | -0.10 | -0.10 | 0.10 |
| EPS Diluted Total Ops | -0.20 | -0.20 | -0.10 | -0.30 | -0.30 |
| EPS Diluted Continuous Ops | -0.42 | 0.10 | 0.01 | -0.20 | -0.40 |
| EPS Diluted Discontinuous Ops | 0.22 | -0.31 | -0.10 | -0.10 | 0.10 |
| EBITDA(a) | $-3,267 | $-668 | $-1,323 | $-1,430 | $-1,986 |